{"data":{"type":"company_profile_ai","id":190067,"entity_id":"wefunder:company:190067","attributes":{"canonical_url":"https://wefunder.com/tibaray","retrieval_urls":{"canonical":"https://wefunder.com/tibaray","json":"https://wefunder.com/tibaray.json","markdown":"https://wefunder.com/tibaray.md","ai_json":"https://wefunder.com/tibaray.ai.json","ai_text":"https://wefunder.com/tibaray.ai.txt","changelog_json":"https://wefunder.com/tibaray.changelog.json","schema":"https://wefunder.com/.well-known/ai-profile-schema.json"},"updated_at":"2026-06-23T01:01:49Z","generated_at":"2026-06-23T02:51:13Z","profile_visibility":{"owner_published":true,"public_search_results":true,"site_search_listed":true,"privacy_mode":"promote","invite_only":false},"company":{"id":190067,"entity_id":"wefunder:company:190067","slug":"tibaray","name":"TibaRay, Inc.","tagline":"Patented Radiotherapy Technology Designed to Help Cure Cancer in a FLASH™","location":"Fremont, CA","website":"https://tibaray.com/","total_amount_raised":329453,"total_investors":138,"is_funded":false,"is_active":true},"key_claims":[{"claim_id":"claim-total-raised","text":"Total raised on Wefunder: 329453","citation":"https://wefunder.com/tibaray#claim-total-raised","provenance":{"source":"FrontCompanySummary#amount_raised","last_verified_at":"2026-06-23T01:01:49Z","as_of":"2026-06-23T02:51:13Z","confidence":"high"},"observed_at":"2026-06-23T01:01:49Z","expires_at":"2026-06-24T01:01:49Z"},{"claim_id":"claim-total-investors","text":"Total investors: 138","citation":"https://wefunder.com/tibaray#claim-total-investors","provenance":{"source":"FrontCompanySummary#number_of_investors","last_verified_at":"2026-06-23T01:01:49Z","as_of":"2026-06-23T02:51:13Z","confidence":"high"},"observed_at":"2026-06-23T01:01:49Z","expires_at":"2026-06-24T01:01:49Z"}],"verified_facts":[{"claim_id":"claim-total-raised","text":"Total raised on Wefunder: 329453","citation":"https://wefunder.com/tibaray#claim-total-raised","provenance":{"source":"FrontCompanySummary#amount_raised","last_verified_at":"2026-06-23T01:01:49Z","as_of":"2026-06-23T02:51:13Z","confidence":"high"},"observed_at":"2026-06-23T01:01:49Z","expires_at":"2026-06-24T01:01:49Z"},{"claim_id":"claim-total-investors","text":"Total investors: 138","citation":"https://wefunder.com/tibaray#claim-total-investors","provenance":{"source":"FrontCompanySummary#number_of_investors","last_verified_at":"2026-06-23T01:01:49Z","as_of":"2026-06-23T02:51:13Z","confidence":"high"},"observed_at":"2026-06-23T01:01:49Z","expires_at":"2026-06-24T01:01:49Z"}],"company_claims":{"tagline":"Patented Radiotherapy Technology Designed to Help Cure Cancer in a FLASH™","story":"TibaRay is building an ultra-fast, ultra-precise radiotherapy platform to dramatically improve cancer outcomes while reducing side effects, cost, and treatment time.We are not just improving cancer therapy. We are redefining what is curable.The SolutionTibaRay enables FLASH—delivering treatment in a fraction of a second instead of minutes, over 400X faster than today’s state-of the art technology. Recent research shows that this can greatly reduce normal tissue damage, allowing for more curative treatments. In addition, twice as many patients can be treated at reduced costs.FLASH radiobiology is a new scientific discovery showing that ultra-rapid radiation can spare healthy tissue without compromising tumor kill. TibaRay's advances in accelerator physics, RF systems, and beam control now make conformal FLASH clinically feasible for the first time.The Tech Powering PHASEROver the past decade TibaRay has been developing revolutionary linear accelerator and RF component technologies invented at Stanford University. More than $27 million has been invested, including more than $13 million in non-dilutive highly competitive federal grants. These technologies are commercial today and will power PHASER in the near future.Our Galactica linac has been designed into the Leo Cancer Care treatment system, marking the first TibaRay Inside™ commercial partnership integrating Galactica into Leo’s complete treatment platform.Market OpportunityWe are initially focusing on cancer care and treating patients with tumors anywhere in the body.The cancer therapy market is $300 billion overall with radiotherapy being $9 billion (currently with 6-8% CAGR).In addition, there’s $20 billion in opportunities for applications in other major illnesses:Cardiac arrhythmias (e.g., ventricular tachycardia*, atrial fibrillation)Pulmonary emphysema*Functional neurologic conditionsArthritis \u0026amp; inflammatory conditionsOthers (potentially Alzheimer’s, etc.)…*First human clinical trials of focused radiotherapy performed by Dr. Bill LooBusiness ModelOur near-term revenue will be generated by delivering our linacs into the TibaRay Inside™ markets, including healthcare, non-destructive testing, and border security applications.Our long-term objective is full commercialization and deployment of the PHASER system, leveraging our proprietary accelerator technology to address large global markets and create multi-billion-dollar revenue opportunities.Competitive AdvantageFully integrated facility with:Large radiation-shielded vault (radiation safety approved)Advanced production capabilities with CNCs and hydrogen brazing bonding furnaceAccelerator production QMS compliant with ISO 13485Recent FeaturesJoin our mission to save millions of lives by transforming cancer radiotherapy—making treatment more effective, more accessible, and safer for patients worldwide.","quick_facts":["Robust IP portfolio with 20+ issued and pending patents on next-generation radiotherapy technology.","Partnership with an innovative radiotherapy technology provider to integrate core technology.","$9 billion global radiotherapy market with adjacent multi-billion dollar applications.","24,000 sq ft fully integrated Silicon Valley facility for prototyping, testing, and production.","Led by a CEO who built a NASDAQ-listed company to a $2B market cap.","Team of world-class physicists, engineers, and clinical advisors."]},"computed_metrics":{"total_amount_raised":329453,"total_investors":138,"team_size":8,"featured_investor_count":2,"faq_count":5,"recent_post_count":0},"quick_facts":[{"claim_id":"claim-fact-1","value":"Robust IP portfolio with 20+ issued and pending patents on next-generation radiotherapy technology.","citation":"https://wefunder.com/tibaray#claim-fact-1","observed_at":"2026-06-23T01:01:49Z","expires_at":"2026-06-30T01:01:49Z"},{"claim_id":"claim-fact-2","value":"Partnership with an innovative radiotherapy technology provider to integrate core technology.","citation":"https://wefunder.com/tibaray#claim-fact-2","observed_at":"2026-06-23T01:01:49Z","expires_at":"2026-06-30T01:01:49Z"},{"claim_id":"claim-fact-3","value":"$9 billion global radiotherapy market with adjacent multi-billion dollar applications.","citation":"https://wefunder.com/tibaray#claim-fact-3","observed_at":"2026-06-23T01:01:49Z","expires_at":"2026-06-30T01:01:49Z"},{"claim_id":"claim-fact-4","value":"24,000 sq ft fully integrated Silicon Valley facility for prototyping, testing, and production.","citation":"https://wefunder.com/tibaray#claim-fact-4","observed_at":"2026-06-23T01:01:49Z","expires_at":"2026-06-30T01:01:49Z"},{"claim_id":"claim-fact-5","value":"Led by a CEO who built a NASDAQ-listed company to a $2B market cap.","citation":"https://wefunder.com/tibaray#claim-fact-5","observed_at":"2026-06-23T01:01:49Z","expires_at":"2026-06-30T01:01:49Z"},{"claim_id":"claim-fact-6","value":"Team of world-class physicists, engineers, and clinical advisors.","citation":"https://wefunder.com/tibaray#claim-fact-6","observed_at":"2026-06-23T01:01:49Z","expires_at":"2026-06-30T01:01:49Z"}],"latest_fundraise":{"id":151775,"entity_id":"wefunder:fundraise:151775","state":"successful","offering_type":"4(a)(6)","structure":"ttw","testing_the_waters":true,"can_invest_now":false,"funding_started_at":null,"funding_closed_at":null},"investor_memos":[],"team":[{"id":6508861,"entity_id":"wefunder:company_role:6508861","name":"Thinh Tran","title":"CEO \u0026 Director","role":"founder","profile_url":"https://wefunder.com/thinh.tran.2"},{"id":6556605,"entity_id":"wefunder:company_role:6556605","name":"Sami Tantawi","title":"CTO, Co-Founder, Director","role":"founder","profile_url":"https://wefunder.com/sami.tantawi"},{"id":6556606,"entity_id":"wefunder:company_role:6556606","name":"Bill Loo, MD, PhD","title":"Chief Medical Advisor, Co-Founder, Director","role":"founder"},{"id":6556607,"entity_id":"wefunder:company_role:6556607","name":"Peter Maxim","title":"Co-Founder, Director","role":"founder","profile_url":"https://wefunder.com/peter.maxim"},{"id":6589817,"entity_id":"wefunder:company_role:6589817","name":"Rebecca Fahrig","title":"Co-Founder","role":"founder"},{"id":6630850,"entity_id":"wefunder:company_role:6630850","name":"Khalil Doheny","role":"employee","profile_url":"https://wefunder.com/khalil.doheny.1"},{"id":6714751,"entity_id":"wefunder:company_role:6714751","name":"Bill Loo, Md, PhD","title":"Founder","role":"founder","profile_url":"https://wefunder.com/bill.loo.md.phd"},{"id":6714862,"entity_id":"wefunder:company_role:6714862","name":"Dzung Wright","role":"employee","profile_url":"https://wefunder.com/dzung.wright"}],"featured_investors":[{"id":13113,"entity_id":"wefunder:company_investor_profile:13113","name":"Tuoc Luong","bio":"https://www.linkedin.com/in/tuocluong/","profile_url":"https://wefunder.com/tuoc.luong","endorsement_quote":"I have 3 investment thesis: 1) Innovative Technology and a moat that is difficult for competitors to cross 2) Does the technology and product provide a benefit for society. Tibaray has both of these qualities. 3) Does the company have the right leader and team to succeed. I think the CEO Thinh Tran has the experience of taking a company from startup to IPO and further (he has shown this in the past). From a technology perspective there are some big name professors from Stanford who are the leading experts in their fields. So Tibaray has the team, the technology moat and what it does benefit society. Love it!"},{"id":13391,"entity_id":"wefunder:company_investor_profile:13391","name":"William Wraith III \u0026 Family","bio":"William Wraith III - Chairman and CEO, The Wraith Group, Inc. Serial Entrepreneur \u0026amp; Philanthropist","profile_url":"https://wefunder.com/the.wraith.family","endorsement_quote":"\"I invest in technologies that have the potential to save millions of lives by defeating the worst of Cancer, Lung, and Cardiovascular diseases—TibaRay's breakthrough in affordable 'FLASH Radiation' being one of the most compelling lifesaving innovations I’ve seen and had the privilege of supporting. Having helped finance Accuray in its early days of bringing CyberKnife to market, I’ve witnessed firsthand how breakthrough innovations in radiation therapy can redefine cancer care. TibaRay represents the next major leap forward—advancing FLASH radiotherapy with the potential to make such treatment dramatically faster, more precise, and far more accessible to patients worldwide. What drives my investment is simple: the opportunity to help bring to market a technology that is fundamentally transforming how we fight cancer. TibaRay combines a world-class team with a bold and clear vision, and a truly differentiated platform with the potential to deliver clinical impacts at a global scale never before possible.\" Bill Wraith III, teaming with sons Steve and Bill IV, has initiated over $300 million in private funding for innovative startups, playing pivotal leadership roles as Chairman, Co-Founder, Lead Funder, and Adviser in advancing next-generation medical and new materials technologies, including FLASH radiotherapy initiatives through his investments in TibaRay. A graduate of Stanford University (BS, MS, MBA), Bill is the recipient of Stanford’s prestigious Gold Spike, the university's highest award for volunteer leadership—recognizing his contributions to funding and lifetime of commitment to advancing research, medicine, and education. In the early 2000's, Bill was awarded an Honorary Doctor of Science degree by the California College of Podiatric Medicine, honoring his leadership, as Chairman of the Board of Trustees, for leading its reorganization, including first endowment funding and merger with Samuel Merritt University in Oakland."}],"relationships":[{"source_entity_id":"wefunder:company:190067","relation":"has_team_member","target_entity_id":"wefunder:user:4969230","target_url":"https://wefunder.com/thinh.tran.2"},{"source_entity_id":"wefunder:company:190067","relation":"has_team_member","target_entity_id":"wefunder:user:5042359","target_url":"https://wefunder.com/sami.tantawi"},{"source_entity_id":"wefunder:company:190067","relation":"has_team_member","target_entity_id":"wefunder:company_role:6556606"},{"source_entity_id":"wefunder:company:190067","relation":"has_team_member","target_entity_id":"wefunder:user:5034586","target_url":"https://wefunder.com/peter.maxim"},{"source_entity_id":"wefunder:company:190067","relation":"has_team_member","target_entity_id":"wefunder:company_role:6589817"},{"source_entity_id":"wefunder:company:190067","relation":"has_team_member","target_entity_id":"wefunder:user:5068301","target_url":"https://wefunder.com/khalil.doheny.1"},{"source_entity_id":"wefunder:company:190067","relation":"has_team_member","target_entity_id":"wefunder:user:5117577","target_url":"https://wefunder.com/bill.loo.md.phd"},{"source_entity_id":"wefunder:company:190067","relation":"has_team_member","target_entity_id":"wefunder:user:5117581","target_url":"https://wefunder.com/dzung.wright"},{"source_entity_id":"wefunder:company:190067","relation":"has_featured_investor","target_entity_id":"wefunder:user:4747224","target_url":"https://wefunder.com/tuoc.luong"},{"source_entity_id":"wefunder:company:190067","relation":"has_featured_investor","target_entity_id":"wefunder:notable_investor:17379","target_url":"https://wefunder.com/the.wraith.family"},{"source_entity_id":"wefunder:company:190067","relation":"has_latest_fundraise","target_entity_id":"wefunder:fundraise:151775"}],"faq":[{"question":"What is the exit plan (acquisition, IPO, merger, etc.) in which investors will be able to see a ROI?","answer":"Hi bugg log : Thank you for the question—this is an important consideration. Our primary focus is to bring our product to market successfully and build a sustainable, profitable company. By demonstrating real clinical value and commercial traction, we believe this will naturally open the door to multiple exit opportunities over time. As we scale, this could include a potential IPO or a strategic merger or acquisition with a major player in the radiotherapy or medical device space. Historicall..."},{"question":"I am wondering what makes you different then other companies saying they can help cure cancer that is raising now? is anybody on your team fully committed to this company? out of 3 I see. 2 are college professors and one is a founder and CEO of his own company.","answer":"Hi John, Thank you for the thoughtful question—this is an important point, and I’m glad you raised it. What differentiates TibaRay is that we are not approaching cancer treatment as a concept—we are building the core enabling technology for next-generation radiotherapy. Specifically, our proprietary linear accelerator platform is designed to deliver ultra-high dose rate (FLASH) radiation, which has the potential to significantly reduce damage to healthy tissue while maintaining tumor control...."},{"question":"What are the relationships between \"Vita Imaging\" and \"TibaRay\" financially, physically, legally, and control wise? How large are the engineering teams? Operations teams? Have either of these groups integrated, qualified, or produced anything? I see a lot of concept and pontif...","answer":"Great questions—happy to clarify. Vita Imaging and TibaRay are separate companies with no shared ownership or finances. I lead both, but each has its own team, investors, and operations. Strategically, they are complementary: Vita focuses on cancer detection, while TibaRay focuses on treatment. We have dedicated engineering and operations teams working on real hardware and systems—not just concepts. This includes active development, testing, and integration work. We are well beyond the concep..."},{"question":"If this entity is losing over $3M per year, when do you plan to become profitable?","answer":"Hello William: In our space, it’s normal to operate at a loss during the development phase—medical device companies typically take 3–7+ years to mature R\u0026amp;D due to technical complexity as well as regulatory and clinical requirements . The key difference with TibaRay is that we have already largely de-risked the core technology and are now transitioning into commercial deployment through partners and early systems. With commercialization underway, our focus is on scaling revenue, with the g..."},{"question":"thanks for swift response! Saturday morning I am making a ton of business investments. few more questions what is your moat? there is a company raising now called CancerVax(stood out to me) I can't tell between you and them which is better. can you tell me the key difference b...","answer":"Great question—and you’re right, both stories sound compelling. The key difference is that we are solving different problems: - TibaRay: advanced radiation platform (hardware + physics) to directly treat tumors - CancerVax: early-stage biotech developing a cancer vaccine to train the immune system Our moat is in deep engineering and system integration—building high-performance linacs, manufacturing them, and integrating into clinical systems. This is very hard to replicate and has a clearer p..."}],"recent_posts":[],"provenance":{"source":"wefunder_public_company_profile","as_of":"2026-06-23T02:51:13Z","claims":{"total_amount_raised":{"source":"FrontCompanySummary#amount_raised","last_verified_at":"2026-06-23T01:01:49Z","as_of":"2026-06-23T02:51:13Z","confidence":"high"},"total_investors":{"source":"FrontCompanySummary#number_of_investors","last_verified_at":"2026-06-23T01:01:49Z","as_of":"2026-06-23T02:51:13Z","confidence":"high"},"active_raise_states":{"source":"Fundraise.visible(nil, nil)","last_verified_at":"2026-03-05T01:42:43Z","as_of":"2026-06-23T02:51:13Z","confidence":"high"},"latest_fundraise_state":{"source":"Fundraise.visible(nil, nil).order(funding_started_at)","last_verified_at":"2026-03-05T01:42:43Z","as_of":"2026-06-23T02:51:13Z","confidence":"medium"}}}}}}